IAIM
IGMS

International Assets Investment Management’s IGM Biosciences IGMS Stock Holding History

International Assets Investment Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-175
Closed -$15K – 1130
2021
Q1 		$15K Hold
175
– – ﹤0.01% 1414
2020
Q4 		$15K Buy
+175
New +$12.3K ﹤0.01% 1280

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

International Assets Investment Management's IGMS Position: Q2 2021 in Review

International Assets Investment Management sold out of IGM Biosciences (IGMS) in Q2 2021, closing a stake of 175 shares — an estimated $15K sold.

International Assets Investment Management first reported a position in IGMS in Q4 2020 and held it in 2 quarters. The position peaked at $15K in Q1 2021. 104 funds tracked by Wall St. Rank hold IGMS as of Q2 2021.

  • International Assets Investment Management reported no remaining IGM Biosciences position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 175 IGM Biosciences shares in Q2 2021, an estimated $15K.
  • International Assets Investment Management first reported a position in IGM Biosciences in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's IGM Biosciences position peaked at $15K in Q1 2021.
  • 104 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.